The emerging approach of the medication represents a significant development in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects multiple pathways – GLP-1 and GIP – resulting https://tirzepatide-peptide502093.idblogz.com/42421694/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment